Epigenomics AG
Research Epigenomics AG (ECX.F) on Bullrun: market cap EUR 786.03K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerECX.F
- ExchangeF
- CountryGermany
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 786.03K
- Financial periodFY2025
- RevenueEUR 24.00K
- Net income-EUR 314.00K
- Free cash flow-EUR 533.00K
Valuation Snapshot
latest market cap is EUR 786.03K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 24.00K | -EUR 314.00K | -EUR 533.00K | n/a | -0.36 | EUR 414.00K | EUR 11.38M | EUR 2.00K |
| FY2024 | EUR 0 | -EUR 3.35M | -EUR 1.20M | n/a | -3.82 | EUR 927.00K | EUR 11.38M | EUR 0 |
| FY2023 | EUR 339.00K | -EUR 4.46M | -EUR 5.71M | 83.2% | -5.23 | EUR 2.10M | EUR 11.89M | EUR 0 |
| FY2022 | EUR 898.00K | -EUR 17.30M | -EUR 10.76M | 47.2% | -21.14 | EUR 7.80M | EUR 12.66M | EUR 0 |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | EUR 786.03K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Epigenomics AG
Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.
Related stock research
Other Healthcare stocks
MAINZ BIOMED B.V. EO 1 (4TO)
Mainz Biomed N.V. (MYNZ)
NanoRepro AG (NN6.DE)
TME PHARM.CONF.IPO EO 1- (0N6A)
SCHOTT Pharma AG & Co. KGaA (1SXP)
Cannovum Cannabis AG (27N0.DE)
Novogenia AG (7V0.DE)
aap Implantate AG (AAQ1.DE)
Carl Zeiss Meditec AG (AFX)
DocCheck AG (AJ91)
TME Pharma N.V. (ALTME)
Bayer AG (BAYER)
Frequently asked questions
What is Epigenomics AG's market cap?
Epigenomics AG's market capitalization is EUR 786.03K.
What does Epigenomics AG do?
Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.